Citigroup Inc Beyond Air, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Beyond Air, Inc. stock. As of the latest transaction made, Citigroup Inc holds 5 shares of XAIR stock, worth $2. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 133,195 100.0%

Holding current value

Previous $71,000 100.0%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$0.36 - $0.64 $47,948 - $85,241	-133,190 Reduced 100.0%	5 $0
Q2 2024 Aug 12, 2024	BUY	$0.54 - $1.67 $68,893 - $213,058	127,580 Added 2272.13%	133,195 $71,000
Q1 2024 May 10, 2024	BUY	$1.3 - $2.15 $2,128 - $3,519	1,637 Added 41.15%	5,615 $9,000
Q4 2023 Feb 09, 2024	BUY	$1.4 - $2.46 $5,079 - $8,924	3,628 Added 1036.57%	3,978 $7,000
Q3 2023 Nov 09, 2023	SELL	$2.31 - $4.18 $16,823 - $30,442	-7,283 Reduced 95.41%	350 $0
Q2 2023 Aug 10, 2023	SELL	$4.26 - $6.92 $222,431 - $361,320	-52,214 Reduced 87.25%	7,633 $32,000
Q1 2023 May 11, 2023	BUY	$5.65 - $7.56 $14,113 - $18,884	2,498 Added 4.36%	59,847 $403,000
Q4 2022 Feb 09, 2023	BUY	$5.47 - $7.9 $292,705 - $422,736	53,511 Added 1394.24%	57,349 $372,000
Q3 2022 Nov 10, 2022	BUY	$7.42 - $11.39 $19,462 - $29,875	2,623 Added 215.88%	3,838 $29,000
Q2 2022 Aug 10, 2022	BUY	$4.96 - $7.83 $5,952 - $9,396	1,200 Added 8000.0%	1,215 $8,000
Q1 2022 May 12, 2022	BUY	$6.33 - $9.53 $94 - $142	15 New	15 $0

Others Institutions Holding XAIR

# of Institutions

Shares Held

15M

Call Options Held

31.6K

Put Options Held

3.4K

View Full List

About Beyond Air, Inc.

Ticker XAIR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 29,888,000
Market Cap $16.1M
Description
Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment ...

More about XAIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account